Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER)

Sachin Kheterpal(Merck & Co., Inc., Rahway, NJ, USA (United States)), Leif Saager(School of the Art Institute of Chicago), Douglas A. Colquhoun(School of the Art Institute of Chicago), Patrick J. McCormick(School of the Art Institute of Chicago), Karsten Bartels(School of the Art Institute of Chicago), Michelle T. Vaughn(School of the Art Institute of Chicago), Lori D. Bash(School of the Art Institute of Chicago), Nirav Shah(School of the Art Institute of Chicago), Timur Dubovoy(School of the Art Institute of Chicago), Roy G. Soto(School of the Art Institute of Chicago), Robert B. Schonberger(Yale University), Michael R. Mathis(School of the Art Institute of Chicago), Amit Bardia(School of the Art Institute of Chicago), Amy Shanks(School of the Art Institute of Chicago)
Anesthesiology
April 9, 2020
Cited by 302


Related Papers